2009 (17 Publikationen)

• Jaissle GB, Leitritz M, Gelisken F, Ziemssen F, Bartz-Schmidt KU, Szurman P. One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2009; 247; 27-33 [IF 2.102]
• Tatar O, Adam A, Shinoda K, Kaiserling E, Boeyden V, Claes C, Eckardt C, Eckert T, Pertile G, Scharioth GB, Yoeruek E, Szurman P, Bartz-Schmidt KU, Grisanti S. Early effects of intravitreal triamcinolone acetonide on inflammation and proliferation in human choroidal neovascularization. Arch Ophthalmol 2009; 127: 275-281 [IF 3.859]
• Neuhann IM, Neuhann TF, Szurman P, Koerner S, Rohrbach JM, Bartz-Schmidt KU. Clinicopathological correlation of 3 patterns of calcification in a hydrophilic acrylic intraocular lens. J Cataract Refract Surg 2009; 35: 593-597 [IF 2.745]
• Jaissle GB, Ulmer A, Henke-Fahle S, Aisenbrey S, Fierlbeck G, Bartz-Schmidt KU, Szurman P. Intraokulares Bevacizumab als palliative Therapie bei Melanommetastasen-assoziiertem rubeotischen Sekundärglaukom. Klin Monatsbl Augenheilkd 2009; 226: 70-72 [IF 0.576]
• Tatar O, Shinoda K, Kaiserling E, Claes C, Eckardt C, Eckert T, Boeyden V, Pertile G, Yoeruek E, Szurman P, Bartz-Schmidt KU, Grisanti S. Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularization. Br J Ophthalmol 2009; 93: 159-165 [IF 2.917]
• Peters S, Tatar O, Spitzer MS, Szurman P, Aisenbrey S, Lüke M, Adam A, Yoeruek E, Grisanti S. Analysis of the neuronal marker protein gene product 9.5 in internal limiting membranes after indocyanine-green assisted peeling. Retina 2009; 29: 243-247 [IF 3.478]
• Spitzer MS, Kaczmarek RT, Yoeruek E, Petermeier K, Wong D, Heimann H, Jaissle GB, Bartz-Schmidt KU, Szurman P. The distribution, release kinetics and biocompatibility of triamcinolone injected and dispersed in silicone oil. Invest Ophthalmol Vis Sci 2009; 50: 2337-2343 [IF 3.582]
• Feudner EM, Engel C, Neuhann IM, Petermeier K, Bartz-Schmidt KU, Szurman P. Virtual reality training improves wet-lab performance of capsulorhexis: results of a randomized, controlled study. Graefes Arch Clin Exp Ophthalmol 2009; 247: 955-963 [IF 2.102]
• Yoeruek E, Saygili O Spitzer MS, Tatar O, Bartz-Schmidt KU, Szurman P. Human anterior lens capusle as a carrier matrix for cultivated human corneal endothelial cells. Cornea 2009; 28: 416-420 [IF 1.853]
• Frank C, Szurman P, Peters S, Zierhut M, Spitzer MS. Spätes Rezidiv einer Spender-assoziierten Endophthalmitis durch Candida glabrata nach Keratoplastik. Klin Monatsbl Augenheilkd 2009; 26: 510-511 [IF 0.576]
• Kaczmarek R, Szurman P, Misiuk-Hojło M, Grzybowski A. Antiproliferative effects of preservative-free triamcinolone acetonide on cultured human retinal pigment epithelial cells. Med Sci Monit 2009; 15: 227-231 [IF 1.514]
• Szurman P, Frank C, Kaczmarek RT, Spitzer MS. Glaskörperersatz als Möglichkeit zur protrahierten Freisetzung von Medikamenten im Glaskörper. Klin Monatsbl Augenheilkd 2009; 226: 718-724 [IF 0.576]
• Petermeier K, Gekeler F, Spitzer MS, Szurman P. Implantation of the multifocal ReSTOR apodized diffractive intraocular lens in adult anisometropic patients with mild to moderate amblyopia. Br J Ophthalmol 2009; 93: 1269-1301 [IF 2.917]
• Petermeier K, Gekeler F, Messias A, Spitzer MS, Haigis W, Szurman P. Intraocular lens power calculation in highly myopic eyes implanted with the Alcon AcrySof® MA60MA. J Cataract Refract Surg 2009; 35: 1575-1581 [2.745]
• Lüke M, Januschowski K, Lüke J, Peters S, Wirtz N, Yörük E, Lüke Ch, Bartz-Schmidt KU, Grisanti S, Szurman P. The effects of ranibizumab (Lucentis®) on retinal function in isolated perfused vertebrate retina. Br J Ophthalmol 2009; 2009; 93: 1396-1400 [IF 2.917]
• Spitzer MS; Chirambo T, Kayange P, Szurman P, Yoeruek E, Bartz-Schmidt KU, Batumba HN. Der Einfluss der HIV-Pandemie auf die Inzidenz maligner Augentumoren im südlichen Malawi (Blantyre). Ophthalmologe 2009; 106: 813-818 [IF 1.133]
• Petermeier K, Messias A, Gekeler F, Spitzer MS, Szurman P. Outcomes of the AcrySof ReSTOR® IOL in myopes, emmetropes, and hyperopes. J Refract Surg 2009; 25: 1103-1109 [IF 1.914]